Pharma valuation is lucrative 15x of Revenue on average..
why?
it is protected by exclusivity granted by FDA...
FDA only approves a drug inly if this one min. 25% better then current on the market..
Pharma valuation is lucrative 15x of Revenue on average..why?it...
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
33.0¢ |
Change
-0.010(2.94%) |
Mkt cap ! $606.3M | |||
| Open | High | Low | Value | Volume |
| 33.5¢ | 34.0¢ | 32.5¢ | $1.196M | 3.599M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 24 | 1190763 | 32.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.0¢ | 196334 | 12 |
View Market Depth
| Last trade - 13.24pm 10/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |